Compare $BCDA vs $KTTA | Chartloom

Compare

$BCDA vs $KTTA

BioCardia Inc · Pasithea Therapeutics Corp

BCDA

BioCardia Inc

KTTA

Pasithea Therapeutics Corp

Compare $BCDA vs $KTTA

Comparing BioCardia Inc and Pasithea Therapeutics Corp

BCDABioCardia Inc

KTTAPasithea Therapeutics Corp

BCDABioCardia Inc

Market cap

$15M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-18.1%

52W performance

-26.8%

FCF yield

-48.9%

KTTAPasithea Therapeutics Corp

Market cap

$16M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

740.5%

YTD performance

-60.7%

52W performance

-43.0%

FCF yield

-113.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BCDA

KTTA

Detailed metrics comparison

BCDA

BioCardia Inc

KTTA

Pasithea Therapeutics Corp

Market Cap

BCDA$15M

KTTA$16M

Enterprise Value

BCDA$11M

KTTA$-30M

Price

BCDA$1.04

KTTA$0.47

P/E Ratio

BCDAN/A

KTTAN/A

P/S Ratio

BCDA36.53x

KTTA26.84x

EV/Sales

BCDA26.98x

KTTA0.00x

EV/EBITDA

BCDA4.97x

KTTA0.00x

P/B Ratio

BCDA5.83x

KTTA0.32x

P/FCF Ratio

BCDAN/A

KTTAN/A

EV/FCF

BCDA-1.50x

KTTA1.69x

PEG Ratio

BCDAN/A

KTTAN/A

Forward P/E (NTM)

BCDAN/A

KTTAN/A

Forward P/S (NTM)

BCDAN/A

KTTAN/A

Revenue (TTM)

BCDA$0

KTTA$0

Revenue Growth (YoY)

BCDAN/A

KTTA740.5%

Forward Rev Growth

BCDA0.0%

KTTA0.0%

Gross Margin (TTM)

BCDA100.0%

KTTA100.5%

Operating Margin (TTM)

BCDA0.0%

KTTA0.0%

EBITDA Margin (TTM)

BCDA0.0%

KTTA0.0%

Net Margin (TTM)

BCDA0.0%

KTTA0.0%

FCF Margin (TTM)

BCDAN/A

KTTAN/A

Net Income (TTM)

BCDA$-6M

KTTA$-21M

FCF (TTM)

BCDA$-8M

KTTA$-18M

EPS (TTM)

BCDA$0.00

KTTA-$0.66

ROE (TTM)

BCDA-22168.0%

KTTA-4949.0%

ROA (TTM)

BCDA-26166.0%

KTTA-4681.0%

ROIC (TTM)

BCDA-22168.0%

KTTA-4949.0%

Cash

BCDA$4M

KTTA$46M

Debt

BCDA$0

KTTA$0

Net Cash/Debt

BCDA$4M

KTTA$46M

Current Ratio (TTM)

BCDA2.09x

KTTA26.25x

Quick Ratio (TTM)

BCDA2.02x

KTTA24.91x

Debt/Equity (TTM)

BCDA0.00x

KTTA0.00x

Debt/Assets (TTM)

BCDA0.0%

KTTA0.0%

Interest Coverage (TTM)

BCDAN/A

KTTAN/A

Net Debt/EBITDA (TTM)

BCDA0.00x

KTTA0.00x

Beta

BCDA0.63

KTTA0.39

52W Performance

BCDA-26.8%

KTTA-43.0%

YTD Performance

BCDA-18.1%

KTTA-60.7%

% from 52W High

BCDA-42.2%

KTTA-77.3%

% from 52W Low

BCDA38.7%

KTTA66.4%

Asset Turnover (TTM)

BCDA0.14x

KTTA0.01x

FCF Yield (TTM)

BCDA-48.9%

KTTA-113.8%

Earnings Yield (TTM)

BCDA-37.8%

KTTA-136.3%

Dividend Yield (TTM)

BCDAN/A

KTTAN/A

Rule of 40

BCDA0.0

KTTA740.5

EV/GP/RG

BCDAN/A

KTTAN/A

Ticker research

View BCDA research View KTTA research

Metric	BCDA BioCardia Inc	KTTA Pasithea Therapeutics Corp
Market & Valuation
Market Cap	$15M	$16M
Enterprise Value	$11M	$-30M
Price	$1.04	$0.47
P/E Ratio	N/A	N/A
P/S Ratio	36.53x	26.84x
EV/Sales	26.98x	0.00x
EV/EBITDA	4.97x	0.00x
P/B Ratio	5.83x	0.32x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.50x	1.69x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	740.5%
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	100.0%	100.5%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-6M	$-21M
FCF (TTM)	$-8M	$-18M
EPS (TTM)	$0.00	-$0.66
ROE (TTM)	-22168.0%	-4949.0%
ROA (TTM)	-26166.0%	-4681.0%
ROIC (TTM)	-22168.0%	-4949.0%
Financial Health
Cash	$4M	$46M
Debt	$0	$0
Net Cash/Debt	$4M	$46M
Current Ratio (TTM)	2.09x	26.25x
Quick Ratio (TTM)	2.02x	24.91x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.63	0.39
52W Performance	-26.8%	-43.0%
YTD Performance	-18.1%	-60.7%
% from 52W High	-42.2%	-77.3%
% from 52W Low	38.7%	66.4%
Efficiency & Yields
Asset Turnover (TTM)	0.14x	0.01x
FCF Yield (TTM)	-48.9%	-113.8%
Earnings Yield (TTM)	-37.8%	-136.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	740.5
EV/GP/RG	N/A	N/A
Ticker research	View BCDA research	View KTTA research

Valuation

P/S Ratio

KTTA

26.84x

BCDA

36.53x

EV/FCF

BCDA

-1.50x

KTTA

1.69x

Growth & revenue

Revenue Growth TTM

KTTA

740.5%

Forward Revenue Growth

BCDA

0.0%

KTTA

0.0%

Profitability & performance

Gross Margin

KTTA

100.5%

BCDA

100.0%

ROE

KTTA

-4949.0%

BCDA

-22168.0%

FCF Yield %

BCDA

-48.9%

KTTA

-113.8%

52-Week Performance

BCDA

-26.8%

KTTA

-43.0%

Detailed metrics comparison

BCDA

BioCardia Inc

KTTA

Pasithea Therapeutics Corp

Market Cap

BCDA$15M

KTTA$16M

Enterprise Value

BCDA$11M

KTTA$-30M

Price

BCDA$1.04

KTTA$0.47

P/E Ratio

BCDAN/A

KTTAN/A

P/S Ratio

BCDA36.53x

KTTA26.84x

EV/Sales

BCDA26.98x

KTTA0.00x

EV/EBITDA

BCDA4.97x

KTTA0.00x

P/B Ratio

BCDA5.83x

KTTA0.32x

P/FCF Ratio

BCDAN/A

KTTAN/A

EV/FCF

BCDA-1.50x

KTTA1.69x

PEG Ratio

BCDAN/A

KTTAN/A

Forward P/E (NTM)

BCDAN/A

KTTAN/A

Forward P/S (NTM)

BCDAN/A

KTTAN/A

Revenue (TTM)

BCDA$0

KTTA$0

Revenue Growth (YoY)

BCDAN/A

KTTA740.5%

Forward Rev Growth

BCDA0.0%

KTTA0.0%

Gross Margin (TTM)

BCDA100.0%

KTTA100.5%

Operating Margin (TTM)

BCDA0.0%

KTTA0.0%

EBITDA Margin (TTM)

BCDA0.0%

KTTA0.0%

Net Margin (TTM)

BCDA0.0%

KTTA0.0%

FCF Margin (TTM)

BCDAN/A

KTTAN/A

Net Income (TTM)

BCDA$-6M

KTTA$-21M

FCF (TTM)

BCDA$-8M

KTTA$-18M

EPS (TTM)

BCDA$0.00

KTTA-$0.66

ROE (TTM)

BCDA-22168.0%

KTTA-4949.0%

ROA (TTM)

BCDA-26166.0%

KTTA-4681.0%

ROIC (TTM)

BCDA-22168.0%

KTTA-4949.0%

Cash

BCDA$4M

KTTA$46M

Debt

BCDA$0

KTTA$0

Net Cash/Debt

BCDA$4M

KTTA$46M

Current Ratio (TTM)

BCDA2.09x

KTTA26.25x

Quick Ratio (TTM)

BCDA2.02x

KTTA24.91x

Debt/Equity (TTM)

BCDA0.00x

KTTA0.00x

Debt/Assets (TTM)

BCDA0.0%

KTTA0.0%

Interest Coverage (TTM)

BCDAN/A

KTTAN/A

Net Debt/EBITDA (TTM)

BCDA0.00x

KTTA0.00x

Beta

BCDA0.63

KTTA0.39

52W Performance

BCDA-26.8%

KTTA-43.0%

YTD Performance

BCDA-18.1%

KTTA-60.7%

% from 52W High

BCDA-42.2%

KTTA-77.3%

% from 52W Low

BCDA38.7%

KTTA66.4%

Asset Turnover (TTM)

BCDA0.14x

KTTA0.01x

FCF Yield (TTM)

BCDA-48.9%

KTTA-113.8%

Earnings Yield (TTM)

BCDA-37.8%

KTTA-136.3%

Dividend Yield (TTM)

BCDAN/A

KTTAN/A

Rule of 40

BCDA0.0

KTTA740.5

EV/GP/RG

BCDAN/A

KTTAN/A

Ticker research

View BCDA research View KTTA research

Metric	BCDA BioCardia Inc	KTTA Pasithea Therapeutics Corp
Market & Valuation
Market Cap	$15M	$16M
Enterprise Value	$11M	$-30M
Price	$1.04	$0.47
P/E Ratio	N/A	N/A
P/S Ratio	36.53x	26.84x
EV/Sales	26.98x	0.00x
EV/EBITDA	4.97x	0.00x
P/B Ratio	5.83x	0.32x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.50x	1.69x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	740.5%
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	100.0%	100.5%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-6M	$-21M
FCF (TTM)	$-8M	$-18M
EPS (TTM)	$0.00	-$0.66
ROE (TTM)	-22168.0%	-4949.0%
ROA (TTM)	-26166.0%	-4681.0%
ROIC (TTM)	-22168.0%	-4949.0%
Financial Health
Cash	$4M	$46M
Debt	$0	$0
Net Cash/Debt	$4M	$46M
Current Ratio (TTM)	2.09x	26.25x
Quick Ratio (TTM)	2.02x	24.91x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.63	0.39
52W Performance	-26.8%	-43.0%
YTD Performance	-18.1%	-60.7%
% from 52W High	-42.2%	-77.3%
% from 52W Low	38.7%	66.4%
Efficiency & Yields
Asset Turnover (TTM)	0.14x	0.01x
FCF Yield (TTM)	-48.9%	-113.8%
Earnings Yield (TTM)	-37.8%	-136.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	740.5
EV/GP/RG	N/A	N/A
Ticker research	View BCDA research	View KTTA research